- •Anti-nAChR autoAbs titer increased in sera of two TMG patients with stable symptoms.
- •The titer's increase correlated with an increase of non-anti-α1 autoAbs.
- •Immunotherapy modification when non-anti-α1 autoAbs increase might not be needed.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4.Autoimmun Rev. 2013; 12: 918-923https://doi.org/10.1016/j.autrev.2013.03.001
- Myasthenia gravis - autoantibody characteristics and their implications for therapy.Nat Rev Neurol. 2016; 12: 259-268https://doi.org/10.1038/nrneurol.2016.44
- Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis.Ann Neurol. 2001; 50: 64-72https://doi.org/10.1002/ana.1017
- Thymoma and paraneoplastic myasthenia gravis.Autoimmunity. 2010; 43: 413-427https://doi.org/10.3109/08916930903555935
- Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study.Eur J Neurol. 2003; 10: 701-706https://doi.org/10.1046/j.1468-1331.2003.00678.x
- Thymoma_associated myasthenia gravis: clinical features and predictive value of antiacetylcholine receptor antibodies in the risk of recurrence of thymoma.Thorac Cancer. 2020; 12: 106-113
- Mammalian nicotinic acetylcholine receptors: from structure to function.Physiol Rev. 2009; 89: 73-120https://doi.org/10.1152/physrev.00015.2008
- The neuromuscular junction in health and disease: molecular mechanisms governing synaptic formation and homeostasis.Front Mol Neurosci. 2020; 13610964https://doi.org/10.3389/fnmol.2020.610964
- The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences.J Neurobiol. 2002; 53: 447-456https://doi.org/10.1002/neu.10153
- Refined structure of the nicotinic acetylcholine receptor at 4A resolution.J Mol Biol. 2005; 346: 967-989https://doi.org/10.1016/j.jmb.2004.12.031
- Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits.Proc Natl Acad Sci U S A. 1980; 77: 755-759https://doi.org/10.1073/pnas.77.2.755
- Antigen-specific apheresis of human anti-acetylcholine receptor autoantibodies from myasthenia gravis patients’ sera using Escherichia coli-expressed receptor domains.J Neuroimmunol. 2008; 200: 133-141https://doi.org/10.1016/j.jneuroim.2008.06.002
- Subunit specificity of the acetylcholine receptor antibodies in double seropositive myasthenia gravis.Muscle Nerve. 2021; 63: E36-E37https://doi.org/10.1002/mus.27177
- Analysis of nAChR Autoantibodies Against Extracellular Epitopes in MG Patients.Front Neurol. 2022; 13
- Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.Neurology. 1976; 26: 1054-1059https://doi.org/10.1212/wnl.26.11.1054
- Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays.J Neurol Neurosurg Psychiatry. 1985; 48: 1246-1252https://doi.org/10.1136/jnnp.48.12.1246
- Extracellular domains of the β, γ and ε subunits of the human acetylcholine receptor as immunoadsorbents for myasthenic autoantibodies: a combination of immunoadsorbents results in increased efficiency.J Neuroimmunol. 2007; 190: 44-52https://doi.org/10.1016/j.jneuroim.2007.07.018
- Specific immunoadsorption of the autoantibodies from myasthenic patients using the extracellular domain of the human muscle acetylcholine receptor α-subunit. Development of an antigen-specific therapeutic strategy.J Neuroimmunol. 2005; 159: 183-191https://doi.org/10.1016/j.jneuroim.2004.10.002
- Heterogeneity of acetylcholine receptor autoantibody–mediated complement activity in patients with myasthenia gravis.Neurol - Neuroimmunol Neuroinflammation. 2022; 9: e1169https://doi.org/10.1212/NXI.0000000000001169